240 related articles for article (PubMed ID: 28690524)
1. Erdheim-Chester Disease: Case Report with Aggressive Multisystem Manifestations and Review of the Literature.
Alotaibi S; Alhafi O; Nasr H; Eltayeb K; Elyamany G
Case Rep Oncol; 2017; 10(2):501-507. PubMed ID: 28690524
[TBL] [Abstract][Full Text] [Related]
2. Erdheim-Chester Disease: a comprehensive review of the literature.
Mazor RD; Manevich-Mazor M; Shoenfeld Y
Orphanet J Rare Dis; 2013 Sep; 8():137. PubMed ID: 24011030
[TBL] [Abstract][Full Text] [Related]
3. BRAF-Mutated Erdheim-Chester Disease: Profound Response to Vemurafenib Visualized With Serial Multimodality Imaging.
Gray JCR; Kim J; Digianvittorio M; Feeley NK; Scheel PJ; Siegelman SS; Fishman EK; Rowe SP
J Natl Compr Canc Netw; 2020 Jun; 18(6):650-655. PubMed ID: 32502983
[TBL] [Abstract][Full Text] [Related]
4. Erdheim-Chester disease (ECD): Case report, clinical and basic investigations, and review of literature.
Adawi M; Bisharat B; Bowirrat A
Medicine (Baltimore); 2016 Oct; 95(42):e5167. PubMed ID: 27759649
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
[TBL] [Abstract][Full Text] [Related]
6. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease.
Haroche J; Abla O
Hematology Am Soc Hematol Educ Program; 2015; 2015():571-8. PubMed ID: 26637774
[TBL] [Abstract][Full Text] [Related]
7. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
Haroche J; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
Expert Rev Clin Immunol; 2015; 11(9):1033-42. PubMed ID: 26197238
[TBL] [Abstract][Full Text] [Related]
8. FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim-Chester Disease with the
Oneal PA; Kwitkowski V; Luo L; Shen YL; Subramaniam S; Shord S; Goldberg KB; McKee AE; Kaminskas E; Farrell A; Pazdur R
Oncologist; 2018 Dec; 23(12):1520-1524. PubMed ID: 30120160
[TBL] [Abstract][Full Text] [Related]
9. The clinical spectrum of Erdheim-Chester disease: an observational cohort study.
Estrada-Veras JI; O'Brien KJ; Boyd LC; Dave RH; Durham B; Xi L; Malayeri AA; Chen MY; Gardner PJ; Alvarado-Enriquez JR; Shah N; Abdel-Wahab O; Gochuico BR; Raffeld M; Jaffe ES; Gahl WA
Blood Adv; 2017 Feb; 1(6):357-366. PubMed ID: 28553668
[TBL] [Abstract][Full Text] [Related]
10. [Erdheim-Chester disease-A histiocytic multisystem disease with unusual renal involvement].
Dasdelen S; Büschek F
Internist (Berl); 2020 Sep; 61(9):969-979. PubMed ID: 32785740
[TBL] [Abstract][Full Text] [Related]
11. Erdheim-Chester disease.
Campochiaro C; Tomelleri A; Cavalli G; Berti A; Dagna L
Eur J Intern Med; 2015 May; 26(4):223-9. PubMed ID: 25865950
[TBL] [Abstract][Full Text] [Related]
12. Erdheim-Chester Disease: a Rare but Important Cause of Recurrent Pericarditis.
Chahine J; Alzubi J; Alnajjar H; Ramchand J; Chetrit M; Klein AL
Curr Cardiol Rep; 2020 Jun; 22(8):75. PubMed ID: 32607694
[TBL] [Abstract][Full Text] [Related]
13. Cladribine treatment for Erdheim-Chester disease involving the central nervous system and concomitant polycythemia vera: A case report.
Tamura S; Kawamoto K; Miyoshi H; Suzuki T; Katagiri T; Kasami T; Nemoto H; Miyakoshi S; Kobayashi H; Shibasaki Y; Masuko M; Takeuchi K; Ohshima K; Sone H; Takizawa J
J Clin Exp Hematop; 2018 Dec; 58(4):161-165. PubMed ID: 30305475
[TBL] [Abstract][Full Text] [Related]
14. Erdheim-Chester disease.
Haroche J; Arnaud L; Cohen-Aubart F; Hervier B; Charlotte F; Emile JF; Amoura Z
Rheum Dis Clin North Am; 2013 May; 39(2):299-311. PubMed ID: 23597965
[TBL] [Abstract][Full Text] [Related]
15. Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series.
Mazor RD; Manevich-Mazor M; Kesler A; Aizenstein O; Eshed I; Jaffe R; Pessach Y; Goldberg I; Sprecher E; Yaish I; Gural A; Ganzel C; Shoenfeld Y
BMC Med; 2014 Dec; 12():221. PubMed ID: 25434739
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis).
Pegoraro F; Papo M; Cohen-Aubart F; Peyronel F; Lugli G; Trambusti I; Baulier G; de Menthon M; Le Scornet T; Oziol E; Ferreira-Maldent N; Hermine O; Faucher B; Koschel D; Straetmans N; Abisror N; Terrier B; Lifermann F; Razanamahery J; Allenbach Y; Keraen J; Bulifon S; Hervier B; Buccoliero A; Charlotte F; Monzani Q; Boussouar S; Shor N; Tondo A; Barete S; Idbaih A; Tazi A; Sieni E; Amoura Z; Emile JF; Vaglio A; Haroche J
EClinicalMedicine; 2024 Jul; 73():102658. PubMed ID: 38841707
[TBL] [Abstract][Full Text] [Related]
17. A Rare Case of Erdheim-Chester Disease (Non-Langerhans Cell Histiocytosis) with Concurrent Langerhans Cell Histiocytosis: A Diagnostic and Therapeutic Challenge.
Hashmi H; Murray D; Greenwell J; Shaikh M; Basu S; Krem M
Case Rep Hematol; 2018; 2018():7865325. PubMed ID: 29888013
[TBL] [Abstract][Full Text] [Related]
18. CNS Erdheim-Chester Disease: A Challenge to Diagnose.
Pan Z; Kleinschmidt-DeMasters BK
J Neuropathol Exp Neurol; 2017 Dec; 76(12):986-996. PubMed ID: 29096034
[TBL] [Abstract][Full Text] [Related]
19. Rare Cutaneous Manifestations of Erdheim Chester Disease: A Case Report and Literature Review.
Vasandani N; Low JE; Liau YH; Ergun A; Balakrishnan T
Cureus; 2023 Jun; 15(6):e40712. PubMed ID: 37485173
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature].
Adam Z; Petrášová H; Řehák Z; Koukalová R; Krejčí M; Pour L; Vetešníková E; Čermák A; Ševčíková S; Szturz P; Král Z; Mayer J
Vnitr Lek; 2016; 62(10):820-832. PubMed ID: 27900869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
